Literature DB >> 25453714

DSM-5: disruptive mood dysregulation disorder.

Uma Rao1.   

Abstract

This paper will describe historical perspectives for the introduction of disruptive mood dysregulation disorder in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), criteria for the diagnosis, as well as information on epidemiology, clinical presentation and longitudinal course, pathophysiology, and treatment. The diagnosis of disruptive mood dysregulation disorder requires frequent, persistent, severe temper outbursts out of proportion to the situation and developmental context in combination with persistent, angry/irritable mood between the temper outbursts. Because of the limited available data, the inclusion of this new diagnosis in DSM-5 has been controversial. Regardless of this controversy, it is clear that youth experiencing such symptoms are highly impaired and utilize significant health services. Therefore, we need to expand our efforts to better understand the complex construct of this phenotype in order to improve the assessment, diagnosis and treatment of this condition.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adolescents; Children; Depressive disorder; Disruptive mood dysregulation disorder; Irritability

Mesh:

Year:  2014        PMID: 25453714      PMCID: PMC4254488          DOI: 10.1016/j.ajp.2014.03.002

Source DB:  PubMed          Journal:  Asian J Psychiatr        ISSN: 1876-2018


  48 in total

1.  Taking disruptive mood dysregulation disorder out for a test drive.

Authors:  David Axelson
Journal:  Am J Psychiatry       Date:  2013-02       Impact factor: 18.112

2.  The dramatic rise in neuroleptic use in children: why do we do it and what does it buy us? Theories from inpatient data 1988-2010.

Authors:  Gabrielle A Carlson
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-04       Impact factor: 2.576

3.  Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling.

Authors:  B Geller; M Williams; B Zimerman; J Frazier; L Beringer; K L Warner
Journal:  J Affect Disord       Date:  1998-11       Impact factor: 4.839

4.  An open-label trial of risperidone in children and adolescents with severe mood dysregulation.

Authors:  Fernanda Valle Krieger; Gabriel Ferreira Pheula; Roberta Coelho; Thamis Zeni; Silzá Tramontina; Cristian Patrick Zeni; Luis Augusto Rohde
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-06       Impact factor: 2.576

5.  Chronic versus episodic irritability in youth: a community-based, longitudinal study of clinical and diagnostic associations.

Authors:  Ellen Leibenluft; Patricia Cohen; Tristan Gorrindo; Judith S Brook; Daniel S Pine
Journal:  J Child Adolesc Psychopharmacol       Date:  2006-08       Impact factor: 2.576

6.  Different psychophysiological and behavioral responses elicited by frustration in pediatric bipolar disorder and severe mood dysregulation.

Authors:  Brendan A Rich; Mariana Schmajuk; Koraly E Perez-Edgar; Nathan A Fox; Daniel S Pine; Ellen Leibenluft
Journal:  Am J Psychiatry       Date:  2007-02       Impact factor: 18.112

7.  Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype?

Authors:  S V Faraone; J Biederman; D Mennin; J Wozniak; T Spencer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-10       Impact factor: 8.829

8.  The Child Behavior Checklist (CBCL) and the CBCL-bipolar phenotype are not useful in diagnosing pediatric bipolar disorder.

Authors:  Rasim Somer Diler; Boris Birmaher; David Axelson; Ben Goldstein; MaryKay Gill; Michael Strober; David J Kolko; Tina R Goldstein; Jeffrey Hunt; Mei Yang; Neal D Ryan; Satish Iyengar; Ronald E Dahl; Lorah D Dorn; Martin B Keller
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

Review 9.  Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability.

Authors:  David Linton; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

10.  DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses.

Authors:  Darrel A Regier; William E Narrow; Diana E Clarke; Helena C Kraemer; S Janet Kuramoto; Emily A Kuhl; David J Kupfer
Journal:  Am J Psychiatry       Date:  2013-01       Impact factor: 18.112

View more
  4 in total

Review 1.  Irritability in Pediatric Patients: Normal or Not?

Authors:  Usman Hameed; Cheryl A Dellasega
Journal:  Prim Care Companion CNS Disord       Date:  2016-03-24

2.  Affective dysregulation: a transdiagnostic research concept between ADHD, aggressive behavior conditions and borderline personality traits.

Authors:  Robert Waltereit; Franziska Giller; Stefan Ehrlich; Veit Roessner
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-12       Impact factor: 4.785

3.  Differential risk for late adolescent conduct problems and mood dysregulation among children with early externalizing behavior problems.

Authors:  Yuko Okado; Karen L Bierman
Journal:  J Abnorm Child Psychol       Date:  2015-05

4.  The History, Diagnosis and Treatment of Disruptive Mood Dysregulation Disorder.

Authors:  Jun Chen; Zuowei Wang; Yiru Fang
Journal:  Shanghai Arch Psychiatry       Date:  2016-10-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.